Loading...

Theodoros Kelesidis

Title(s)Associate Professor-in-Residence, Medicine
SchoolMedicine
Phone310-825-7875
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Targeting early instigators of vascular inflammation to prevent and/or delay vascular aging in chronic treated HIV
    NIH/NIA R01AG059502Sep 30, 2018 - May 31, 2023
    Role: Principal Investigator
    Elucidating the impact of molecular signatures of immune senescence on aging in chronic treated HIV
    NIH/NIA R03AG059462Aug 1, 2018 - Apr 30, 2020
    Role: Principal Investigator
    In vivo modelling of therapeutic strategies for prevention of HIV-related fibrosis and fatty liver disease in chronic treated HIV-1 infection
    NIH/NIAID R21AI136708Jul 1, 2018 - Jun 30, 2020
    Role: Principal Investigator
    Humanized mice as a model to study novel therapies for HIV-Associated Neurocognitive Disorders (HAND) in elderly HIV-1 infected individuals
    NIH/NIA R03AG056189Dec 1, 2017 - Nov 30, 2019
    Role: Principal Investigator
    Humanized mice as a model to study the role of oxidized lipids in HIV-related cardiovascular disease
    NIH/NHLBI R21HL134444Sep 15, 2016 - Jul 31, 2018
    Role: Principal Investigator
    Oxidized HDL in the intersection of HIV, immune activation and atherosclerosis
    NIH/NIAID K08AI108272Aug 12, 2013 - Jul 31, 2018
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Brown TT, Moser C, Currier JS, Ribaudo HJ, Rothenberg J, Kelesidis T, Yang O, Dubé MP, Murphy RL, Stein JH, McComsey GA. Erratum to: Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. J Infect Dis. 2020 Feb 05. PMID: 32022230.
      View in: PubMed
    2. Adamson PC, Judson SD, Klausner JD, Kelesidis T. Neisseria gonorrhoeae as a Rare Cause of Preseptal Cellulitis. Sex Transm Dis. 2019 12; 46(12):813-815. PMID: 31356532.
      View in: PubMed
    3. Sarkar S, Haberlen S, Whelton S, E Schneider E, Kingsley L, Palella F, Witt MD, Kelesidis T, Rodriguez A, Post WS, Brown TT. Greater IL-6, D-dimer, and ICAM-1 Levels Are Associated With Lower Small HDL Particle Concentration in the Multicenter AIDS Cohort Study. Open Forum Infect Dis. 2019 Dec; 6(12):ofz474. PMID: 32128324.
      View in: PubMed
    4. Pagonas N, Vlatsas S, Bauer F, Seibert FS, Sasko B, Buschmann I, Ritter O, Kelesidis T, Westhoff TH. The impact of aerobic and isometric exercise on different measures of dysfunctional high-density lipoprotein in patients with hypertension. Eur J Prev Cardiol. 2019 Aug; 26(12):1301-1309. PMID: 31067131.
      View in: PubMed
    5. Tuccinardi D, Farr OM, Upadhyay J, Oussaada SM, Mathew H, Paschou SA, Perakakis N, Koniaris A, Kelesidis T, Mantzoros CS. Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six-month, randomized, placebo-controlled, double-blind clinical trial. Diabetes Obes Metab. 2019 06; 21(6):1487-1492. PMID: 30724455.
      View in: PubMed
    6. Samadi S, Mehramiz M, Kelesidis T, Mobarhan MG, Sahebkar AH, Esmaily H, Moohebati M, Farjami Z, Ferns GA, Mohammadpour AH, Avan A. High-density lipoprotein lipid peroxidation as a molecular signature of the risk for developing cardiovascular disease: Results from MASHAD cohort. J Cell Physiol. 2019 Feb 19. PMID: 30784041.
      View in: PubMed
    7. Samadi S, Abolbashari S, Meshkat Z, Mohammadpour AH, Kelesidis T, Gholoobi A, Mehramiz M, Tabadkani M, Sadabadi F, Dalirfardouei R, Ferns GA, Ghayour-Mobarhan M, Avan A. Human T lymphotropic virus type 1 and risk of cardiovascular disease: High-density lipoprotein dysfunction versus serum HDL-C concentrations. Biofactors. 2019 May; 45(3):374-380. PMID: 30693992.
      View in: PubMed
    8. Christodoulides A, Gupta N, Yacoubian V, Maithel N, Parker J, Kelesidis T. The Role of Lipoproteins in Mycoplasma-Mediated Immunomodulation. Front Microbiol. 2018; 9:1682. PMID: 30108558.
      View in: PubMed
    9. Kelesidis T, Moser CB, Johnston E, Stein JH, Dube MP, Yang OO, McComsey GA, Currier JS, Brown TT. Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s. J Acquir Immune Defic Syndr. 2018 07 01; 78(3):362-366. PMID: 29533303.
      View in: PubMed
    10. Kelesidis T, Kendall MA, Danoff A, Aberg JA, Currier JS, Schmidt AM. Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332. Medicine (Baltimore). 2018 Jun; 97(22):e10955. PMID: 29851842.
      View in: PubMed
    11. Seang S, Kelesidis T, Huynh D, Park S, Moe AA, Currier JS, Lake JE. Low Levels of Endothelial Progenitor Cells and Their Association with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men. AIDS Res Hum Retroviruses. 2018 01; 34(1):39-45. PMID: 29226690.
      View in: PubMed
    12. Angelovich TA, Hearps AC, Oda MN, Borja MS, Huynh D, Homann S, Jaworowski A, Kelesidis T. Dysfunctional high-density lipoprotein from HIV+ individuals promotes monocyte-derived foam cell formation in vitro. AIDS. 2017 11 13; 31(17):2331-2336. PMID: 28926407.
      View in: PubMed
    13. Angelovich TA, Hearps AC, Maisa A, Kelesidis T, Jaworowski A. Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions. J Vis Exp. 2017 10 17; (128). PMID: 29155735.
      View in: PubMed
    14. Sen Roy S, Nguyen HCX, Angelovich TA, Hearps AC, Huynh D, Jaworowski A, Kelesidis T. Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein. J Vis Exp. 2017 10 12; (128). PMID: 29053671.
      View in: PubMed
    15. Homann S, Hofmann C, Gorin AM, Nguyen HCX, Huynh D, Hamid P, Maithel N, Yacoubian V, Mu W, Kossyvakis A, Sen Roy S, Yang OO, Kelesidis T. A novel rapid and reproducible flow cytometric method for optimization of transfection efficiency in cells. PLoS One. 2017; 12(9):e0182941. PMID: 28863132.
      View in: PubMed
    16. Kelesidis T, Oda MN, Borja MS, Yee Y, Ng KF, Huynh D, Elashoff D, Currier JS. Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals. J Acquir Immune Defic Syndr. 2017 07 01; 75(3):354-363. PMID: 28346318.
      View in: PubMed
    17. Christodoulides A, Boyadjian A, Kelesidis T. Spirochetal Lipoproteins and Immune Evasion. Front Immunol. 2017; 8:364. PMID: 28424696.
      View in: PubMed
    18. Vergidis P, Ariza-Heredia EJ, Nellore A, Kotton CN, Kaul DR, Morris MI, Kelesidis T, Shah H, Park SY, Nguyen MH, Razonable RR. Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients1. Emerg Infect Dis. 2017 03; 23(3):510-512. PMID: 28221102.
      View in: PubMed
    19. Kim JY, Kelesidis T, Yang OO. Detection of Donor-Derived Microparticles in the Peripheral Blood of a Hand Transplant Recipient During Rejection. Transplant Direct. 2017 Mar; 3(3):e131. PMID: 28361115.
      View in: PubMed
    20. Kelesidis T, Schmid I. Assessment of Telomere Length, Phenotype, and DNA Content. Curr Protoc Cytom. 2017 01 05; 79:7.26.1-7.26.23. PMID: 28055113.
      View in: PubMed
    21. Kelesidis T, Jackson N, McComsey GA, Wang X, Elashoff D, Dube MP, Brown TT, Yang OO, Stein JH, Currier JS. Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection. AIDS. 2016 11 13; 30(17):2625-2633. PMID: 27603288.
      View in: PubMed
    22. Davidson WS, Inge TH, Sexmith H, Heink A, Elder D, Hui DY, Melchior JT, Kelesidis T, Shah AS. Weight loss surgery in adolescents corrects high-density lipoprotein subspecies and their function. Int J Obes (Lond). 2017 01; 41(1):83-89. PMID: 27780977.
      View in: PubMed
    23. Kelesidis T, Tran TTT, Brown TT, Moser C, Ribaudo HJ, Dube MP, Yang OO, McComsey GA, Stein JH, Currier JS. Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s. Antivir Ther. 2017; 22(2):113-126. PMID: 27661466.
      View in: PubMed
    24. Lake JE, Seang S, Kelesidis T, Currier JS, Yang OO. Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study. HIV Clin Trials. 2016 11; 17(6):225-232. PMID: 27658740.
      View in: PubMed
    25. Dirajlal-Fargo S, Moser C, Brown TT, Kelesidis T, Dube MP, Stein JH, Currier J, McComsey GA. Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s. Open Forum Infect Dis. 2016 Sep; 3(3):ofw174. PMID: 27704026.
      View in: PubMed
    26. Danoff A, Kendall MA, Currier JS, Kelesidis T, Schmidt AM, Aberg JA. Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332. Inflammation. 2016 Aug; 39(4):1354-62. PMID: 27216802.
      View in: PubMed
    27. Kelesidis T, Moser C, Stein JH, Brown TT, Tran TT, Ribaudo HJ, Dube MP, Yang OO, Currier JS, McComsey GA. Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. J Infect Dis. 2016 09 01; 214(5):748-52. PMID: 27354367.
      View in: PubMed
    28. McComsey GA, Moser C, Currier J, Ribaudo HJ, Paczuski P, Dubé MP, Kelesidis T, Rothenberg J, Stein JH, Brown TT. Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s. Clin Infect Dis. 2016 Apr 01; 62(7):853-62. PMID: 26797215.
      View in: PubMed
    29. Baghdadi J, Hemarajata P, Humphries R, Kelesidis T. First Report of Ventriculoperitoneal Shunt Infection due to Cyberlindnera fabianii. Case Rep Infect Dis. 2015; 2015:630816. PMID: 26618013.
      View in: PubMed
    30. Kelesidis T, Braykov N, Uslan DZ, Morgan DJ, Gandra S, Johannsson B, Schweizer ML, Weisenberg SA, Young H, Cantey J, Perencevich E, Septimus E, Srinivasan A, Laxminarayan R. Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational Study. Infect Control Hosp Epidemiol. 2016 Jan; 37(1):70-9. PMID: 26456803.
      View in: PubMed
    31. Kelesidis T, Papakonstantinou V, Detopoulou P, Fragopoulou E, Chini M, Lazanas MC, Antonopoulou S. The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection. AIDS Rev. 2015 Oct-Dec; 17(4):191-201. PMID: 26616844.
      View in: PubMed
    32. Kelesidis T, Falagas ME. The safety of polymyxin antibiotics. Expert Opin Drug Saf. 2015; 14(11):1687-701. PMID: 26365594.
      View in: PubMed
    33. Lake JE, Seang S, Kelesidis T, Liao DH, Hodis HN, Stein JH, Currier JS. Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot study. HIV Clin Trials. 2015 Oct; 16(5):197-206. PMID: 26360501.
      View in: PubMed
    34. Hindler JA, Wong-Beringer A, Charlton CL, Miller SA, Kelesidis T, Carvalho M, Sakoulas G, Nonejuie P, Pogliano J, Nizet V, Humphries R. In vitro activity of daptomycin in combination with ß-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci. Antimicrob Agents Chemother. 2015 Jul; 59(7):4279-88. PMID: 25963982.
      View in: PubMed
    35. Brown TT, Moser C, Currier JS, Ribaudo HJ, Rothenberg J, Kelesidis T, Yang O, Dubé MP, Murphy RL, Stein JH, McComsey GA. Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. J Infect Dis. 2015 Oct 15; 212(8):1241-9. PMID: 25948863.
      View in: PubMed
    36. Kelesidis T, Tran TT, Stein JH, Brown TT, Moser C, Ribaudo HJ, Dube MP, Murphy R, Yang OO, Currier JS, McComsey GA. Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. Clin Infect Dis. 2015 Aug 15; 61(4):651-60. PMID: 25904376.
      View in: PubMed
    37. Kelesidis T, Falagas ME. Substandard/counterfeit antimicrobial drugs. Clin Microbiol Rev. 2015 Apr; 28(2):443-64. PMID: 25788516.
      View in: PubMed
    38. Kelesidis T, Mastoris I, Metsini A, Tsiodras S. How to approach and treat viral infections in ICU patients. BMC Infect Dis. 2014 Nov 28; 14:321. PMID: 25431007.
      View in: PubMed
    39. Braykov NP, Morgan DJ, Schweizer ML, Uslan DZ, Kelesidis T, Weisenberg SA, Johannsson B, Young H, Cantey J, Srinivasan A, Perencevich E, Septimus E, Laxminarayan R. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis. 2014 Dec; 14(12):1220-7. PMID: 25455989.
      View in: PubMed
    40. Kelesidis T, Roberts CK, Huynh D, Martínez-Maza O, Currier JS, Reddy ST, Yang OO. A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL. PLoS One. 2014; 9(11):e111716. PMID: 25368900.
      View in: PubMed
    41. Yang OO, Kelesidis T, Cordova R, Khanlou H. Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial. AIDS Res Hum Retroviruses. 2014 Oct; 30(10):988-95. PMID: 25127924.
      View in: PubMed
    42. Kelesidis T, Currier JS. Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection. Endocrinol Metab Clin North Am. 2014 Sep; 43(3):665-84. PMID: 25169560.
      View in: PubMed
    43. Kelesidis T, Currier JS, Yang OO, Brown TT. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. AIDS Rev. 2014 Jul-Sep; 16(3):123-33. PMID: 25102334.
      View in: PubMed
    44. Kelesidis T. The Cross-Talk between Spirochetal Lipoproteins and Immunity. Front Immunol. 2014; 5:310. PMID: 25071771.
      View in: PubMed
    45. Tewhey R, Gu B, Kelesidis T, Charlton C, Bobenchik A, Hindler J, Schork NJ, Humphries RM. Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing. mBio. 2014 May 13; 5(3):e00894-14. PMID: 24915435.
      View in: PubMed
    46. Zanni MV, Kelesidis T, Fitzgerald ML, Lo J, Abbara S, Wai B, Marmarelis E, Hernandez NJ, Yang OO, Currier JS, Grinspoon SK. HDL redox activity is increased in HIV-infected men in association with macrophage activation and non-calcified coronary atherosclerotic plaque. Antivir Ther. 2014; 19(8):805-811. PMID: 24535655.
      View in: PubMed
    47. Kelesidis T. The Interplay between Daptomycin and the Immune System. Front Immunol. 2014; 5:52. PMID: 24575098.
      View in: PubMed
    48. Kelesidis T. The zoonotic potential of daptomycin non-susceptible enterococci. Zoonoses Public Health. 2015 Feb; 62(1):1-6. PMID: 24274811.
      View in: PubMed
    49. Giltner CL, Kelesidis T, Hindler JA, Bobenchik AM, Humphries RM. Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2014 Jan; 52(1):357-61. PMID: 24153125.
      View in: PubMed
    50. Roberts CK, Katiraie M, Croymans DM, Yang OO, Kelesidis T. Untrained young men have dysfunctional HDL compared with strength-trained men irrespective of body weight status. J Appl Physiol (1985). 2013 Oct 01; 115(7):1043-9. PMID: 23887902.
      View in: PubMed
    51. Kelesidis T, Humphries R, Chow ALP, Tsiodras S, Uslan DZ. Emergence of daptomycin-non-susceptible enterococci urinary tract isolates. J Med Microbiol. 2013 Jul; 62(Pt 7):1103-1105. PMID: 23598376.
      View in: PubMed
    52. Kelesidis T, Chow AL. Proximity to animal or crop operations may be associated with de novo daptomycin-non-susceptible Enterococcus infection. Epidemiol Infect. 2014 Jan; 142(1):221-4. PMID: 23587411.
      View in: PubMed
    53. Kelesidis T, Tewhey R, Humphries RM. Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome. J Antimicrob Chemother. 2013 Aug; 68(8):1926-8. PMID: 23580562.
      View in: PubMed
    54. Kelesidis T, Yang OO, Kendall MA, Hodis HN, Currier JS. Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults. Lipids Health Dis. 2013 Mar 05; 12:23. PMID: 23510548.
      View in: PubMed
    55. Kelesidis T, Kendall MA, Yang OO, Hodis H, Currier JS. Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study. AIDS Res Hum Retroviruses. 2013 Jun; 29(6):938-48. PMID: 23351153.
      View in: PubMed
    56. Kelesidis T. Transport of daptomycin resistance genes between animals and humans as a possible mechanism for development of de novo daptomycin resistance in enterococci. Epidemiol Infect. 2013 Oct; 141(10):2185-6. PMID: 23253208.
      View in: PubMed
    57. Kelesidis T, Kendall MA, Yang OO, Hodis HN, Currier JS. Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection. J Infect Dis. 2012 Nov 15; 206(10):1558-67. PMID: 23066162.
      View in: PubMed
    58. Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM. The emerging problem of linezolid-resistant Staphylococcus. J Antimicrob Chemother. 2013 Jan; 68(1):4-11. PMID: 22949625.
      View in: PubMed
    59. Humphries RM, Kelesidis T, Tewhey R, Rose WE, Schork N, Nizet V, Sakoulas G. Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2012 Nov; 56(11):6051-3. PMID: 22948885.
      View in: PubMed
    60. Kelesidis T, Reddy ST, Huynh D, Meriwether D, Fogelman AM, Navab M, Yang OO. Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity. Lipids Health Dis. 2012 Jul 06; 11:87. PMID: 22768920.
      View in: PubMed
    61. Kelesidis T, Tsiodras S. Extraparenchymal neurocysticercosis in the United States. Am J Med Sci. 2012 Jul; 344(1):79-82. PMID: 22222333.
      View in: PubMed
    62. Kelesidis T, Humphries R, Terashita D, Eshaghian S, Territo MC, Said J, Lewinski M, Currier JS, Pegues D. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County. J Med Virol. 2012 May; 84(5):777-85. PMID: 22431026.
      View in: PubMed
    63. Kelesidis T, Humphries R, Uslan DZ, Pegues D. De novo daptomycin-nonsusceptible enterococcal infections. Emerg Infect Dis. 2012 Apr; 18(4):674-6. PMID: 22469288.
      View in: PubMed
    64. Kelesidis T, Pothoulakis C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol. 2012 Mar; 5(2):111-25. PMID: 22423260.
      View in: PubMed
    65. Tsiodras S, Drogari-Apiranthitou M, Pilichos K, Leventakos K, Kelesidis T, Buitrago MJ, Petrikkos G, Panayiotides I. An unusual cutaneous tumor: African histoplasmosis following mudbaths: case report and review. Am J Trop Med Hyg. 2012 Feb; 86(2):261-3. PMID: 22302860.
      View in: PubMed
    66. Kelesidis T, Chow AL, Humphries R, Uslan DZ, Pegues D. Case-control study comparing de novo and daptomycin-exposed daptomycin-nonsusceptible Enterococcus infections. Antimicrob Agents Chemother. 2012 Apr; 56(4):2150-2. PMID: 22252808.
      View in: PubMed
    67. Kelesidis T. Gastrointestinal symptoms among ambulatory HIV patients: appropriate symptom management requires improved symptom recognition. Ann Gastroenterol. 2012; 25(3):186-187. PMID: 24714135.
      View in: PubMed
    68. Kelesidis T. Comment on: Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections. J Antimicrob Chemother. 2012 Feb; 67(2):515-6. PMID: 22052687.
      View in: PubMed
    69. Kelesidis T, Currier JS, Huynh D, Meriwether D, Charles-Schoeman C, Reddy ST, Fogelman AM, Navab M, Yang OO. A biochemical fluorometric method for assessing the oxidative properties of HDL. J Lipid Res. 2011 Dec; 52(12):2341-51. PMID: 21957198.
      View in: PubMed
    70. Kelesidis T, Theodoros K, Tsiodras S, Sotirios T. Successful treatment of azole-resistant Candida spondylodiscitis with high-dose caspofungin monotherapy. Rheumatol Int. 2012 Sep; 32(9):2957-8. PMID: 21892653.
      View in: PubMed
    71. Kelesidis T, Humphries R, Ward K, Lewinski MA, Yang OO. Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia. Diagn Microbiol Infect Dis. 2011 Nov; 71(3):286-90. PMID: 21855248.
      View in: PubMed
    72. Kelesidis T, Tsiodras S. Extraparenchymal neurocysticercosis in the United States: a case report. J Med Case Rep. 2011 Aug 09; 5:359. PMID: 21827687.
      View in: PubMed
    73. Kelesidis T, Kelesidis I, Lewinski MA, Humphries R. Establishing diagnosis of Haemophilus parainfluenzae as etiology of culture-negative endocarditis using DNA sequence analysis on tissue specimen. Am J Med. 2011 Jul; 124(7):e9-e10. PMID: 21683823.
      View in: PubMed
    74. Kelesidis T, Thian N. Multiple intraventricular neurocysticercal cysts treated with endoscopy without antiparasitic therapy. Am J Trop Med Hyg. 2011 Jul; 85(1):1-2. PMID: 21734115.
      View in: PubMed
    75. Kelesidis T, Aish L, Steller MA, Aish IS, Shen J, Foukas P, Panayiotides J, Petrikkos G, Karakitsos P, Tsiodras S. Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection. Am J Clin Pathol. 2011 Jul; 136(1):119-27. PMID: 21685039.
      View in: PubMed
    76. Kelesidis T, Landovitz RJ. Preexposure prophylaxis for HIV prevention. Curr HIV/AIDS Rep. 2011 Jun; 8(2):94-103. PMID: 21465112.
      View in: PubMed
    77. Kelesidis T, Tsiodras S. Hypopituitarism caused by neurocysticercosis. Am J Med Sci. 2011 May; 341(5):414-6. PMID: 21289508.
      View in: PubMed
    78. Kelesidis T. Bloodstream infection with Anaerobiospirillum succiniciproducens: a potentially lethal infection. South Med J. 2011 Mar; 104(3):205-14. PMID: 21297548.
      View in: PubMed
    79. Kelesidis T, Yang OO, Currier JS, Navab K, Fogelman AM, Navab M. HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL. Lipids Health Dis. 2011 Feb 23; 10:35. PMID: 21345230.
      View in: PubMed
    80. Kelesidis T, Raphael J, Blanchard E. Correction:Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report. J Med Case Rep. 2011 Feb 22; 5:73. PMID: 21342512.
      View in: PubMed
    81. Kelesidis T, Humphries R, Uslan DZ, Pegues DA. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis. 2011 Jan 15; 52(2):228-34. PMID: 21288849.
      View in: PubMed
    82. Kelesidis T, Tsiodras S. Clostridium sphenoides bloodstream infection in man. Emerg Infect Dis. 2011 Jan; 17(1):156-8. PMID: 21192891.
      View in: PubMed
    83. Kelesidis T, Daikos G, Boumpas D, Tsiodras S. Does rituximab increase the incidence of infectious complications? A narrative review. Int J Infect Dis. 2011 Jan; 15(1):e2-16. PMID: 21074471.
      View in: PubMed
    84. Humphries RM, Kelesidis T, Dien Bard J, Ward KW, Bhattacharya D, Lewinski MA. Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin. J Med Microbiol. 2010 Nov; 59(Pt 11):1383-6. PMID: 20688947.
      View in: PubMed
    85. Kelesidis T, Raphael J, Blanchard E, Parameswaran R. Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report. J Med Case Rep. 2010 07 29; 4:231. PMID: 20670435.
      View in: PubMed
    86. Kelesidis T, Tsiodras S. Staphylococcus intermedius is not only a zoonotic pathogen, but may also cause skin abscesses in humans after exposure to saliva. Int J Infect Dis. 2010 Oct; 14(10):e838-41. PMID: 20934636.
      View in: PubMed
    87. Kelesidis T, Osman S, Dinerman H. An unusual foreign body as cause of chronic sinusitis: a case report. J Med Case Rep. 2010 May 26; 4:157. PMID: 20504350.
      View in: PubMed
    88. Mantzoros CS, Sweeney L, Williams CJ, Oken E, Kelesidis T, Rifas-Shiman SL, Gillman MW. Maternal diet and cord blood leptin and adiponectin concentrations at birth. Clin Nutr. 2010 Oct; 29(5):622-6. PMID: 20363059.
      View in: PubMed
    89. Kelesidis T, Dien Bard J, Humphries R, Ward K, Lewinski MA, Uslan DZ. First report of treatment of Anaerobiospirillum succiniciproducens bloodstream infection with levofloxacin. J Clin Microbiol. 2010 May; 48(5):1970-3. PMID: 20305011.
      View in: PubMed
    90. Kelesidis T, Fleisher J, Tsiodras S. Anaphylactoid reaction considered ciprofloxacin related: a case report and literature review. Clin Ther. 2010 Mar; 32(3):515-26. PMID: 20399988.
      View in: PubMed
    91. Yang OO, Kelesidis T. Interleukin-2-unresponsive immune defects in good syndrome: Letter to the Editor. Clin Immunol. 2010 Jun; 135(3):496-8. PMID: 20185370.
      View in: PubMed
    92. Kelesidis T, Salhotra A, Fleisher J, Uslan DZ. Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections? J Infect. 2010 May; 60(5):386-96. PMID: 20176052.
      View in: PubMed
    93. Kelesidis T, Yang O. Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence. Clin Immunol. 2010 Jun; 135(3):347-63. PMID: 20149753.
      View in: PubMed
    94. Kelesidis T, Maysky M, Kelesidis I. Giant right atrium with severe pulmonary hypertension. CMAJ. 2010 Feb 23; 182(3):E147. PMID: 20142373.
      View in: PubMed
    95. Kelesidis T, Canseco E. Giant inguinoscrotal hernia as a cause of hydronephrosis. Am J Med Sci. 2010 Feb; 339(2):174. PMID: 19996734.
      View in: PubMed
    96. Kelesidis T, Canseco E. Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect. Am J Med. 2010 Feb; 123(2):e5-6. PMID: 20103009.
      View in: PubMed
    97. Kelesidis T, Tsiodras S. Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option? Scand J Infect Dis. 2010; 42(1):12-21. PMID: 20055725.
      View in: PubMed
    98. Kelesidis T, Osman S, Trayner E, Worthington M, Celli B. Tracheobronchitis caused by methicillin-resistant Staphylococcus aureus as a cause of chronic wheezing in a non-ventilated adult patient with tracheobronchomalacia. Respiration. 2010; 80(2):148-56. PMID: 20051680.
      View in: PubMed
    99. Kelesidis T, Kelesidis I. Unexplained high fever in an elderly patient treated with clonidine, duloxetine, and atorvastatin. Clin Ther. 2009 Dec; 31(12):2894-9. PMID: 20110028.
      View in: PubMed
    100. Kelesidis T, Tsiodras S. Postirradiation Klebsiella pneumoniae-associated necrotizing fasciitis in the western hemisphere: a rare but life-threatening clinical entity. Am J Med Sci. 2009 Sep; 338(3):217-24. PMID: 19581796.
      View in: PubMed
    101. Kelesidis T, Tarbox A, Lopez M, Aish L. Perineurioma of esophagus: a first case report. Am J Med Sci. 2009 Sep; 338(3):230-2. PMID: 19636242.
      View in: PubMed
    102. Kelesidis T, Osman S, Tsiodras S. Emphysematous cystitis in the absence of known risk factors: an unusual clinical entity. South Med J. 2009 Sep; 102(9):942-6. PMID: 19668051.
      View in: PubMed
    103. Kelesidis T, Tozzi S, Mitty R, Worthington M, Fleisher J. Cytomegalovirus pseudotumor of the duodenum in a patient with AIDS: an unrecognized and potentially treatable clinical entity. Int J Infect Dis. 2010 Apr; 14(4):e274-82. PMID: 19695917.
      View in: PubMed
    104. Kelesidis T, Canseco E. Levofloxacin-induced hypoglycemia: a rare but life-threatening side effect of a widely used antibiotic. Am J Med. 2009 Mar; 122(3):e3-4. PMID: 19272472.
      View in: PubMed
    105. Mantzoros CS, Rifas-Shiman SL, Williams CJ, Fargnoli JL, Kelesidis T, Gillman MW. Cord blood leptin and adiponectin as predictors of adiposity in children at 3 years of age: a prospective cohort study. Pediatrics. 2009 Feb; 123(2):682-9. PMID: 19171638.
      View in: PubMed
    106. Kelesidis T, Karageorgopoulos DE, Kelesidis I, Falagas ME. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother. 2008 Nov; 62(5):895-904. PMID: 18676620.
      View in: PubMed
    107. Kugeler KJ, Mead PS, McGowan KL, Burnham JM, Hogarty MD, Ruchelli E, Pollard K, Husband B, Conley C, Rivera T, Kelesidis T, Lee WM, Mabey W, Winchell JM, Stang HL, Staples JE, Chalcraft LJ, Petersen JM. Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood. J Clin Microbiol. 2008 Jul; 46(7):2428-31. PMID: 18495864.
      View in: PubMed
    108. Kelesidis T, Balba G, Worthington M. Axillary abscess in a patient with Yersinia enterocolitica infection as a result of exposure to pork. Am J Med. 2008 Mar; 121(3):e1. PMID: 18328287.
      View in: PubMed
    109. Tsiodras S, Kelesidis T, Kelesidis I, Bauchinger U, Falagas ME. Human infections associated with wild birds. J Infect. 2008 Feb; 56(2):83-98. PMID: 18096237.
      View in: PubMed
    110. Falagas ME, Karveli EA, Kelesidis I, Kelesidis T. Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis. 2007 Dec; 26(12):857-68. PMID: 17701432.
      View in: PubMed
    111. Blüher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S, Williams CJ, Mantzoros CS. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care. 2007 Feb; 30(2):280-5. PMID: 17259495.
      View in: PubMed
    112. Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros CS, Hankinson SE. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab. 2007 Apr; 92(4):1510-6. PMID: 17213279.
      View in: PubMed
    113. Körner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A, Tseleni S, Mitsiades N, Kiess W, Mantzoros CS. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab. 2007 Mar; 92(3):1041-8. PMID: 17192291.
      View in: PubMed
    114. Bullen JW, Bluher S, Kelesidis T, Mantzoros CS. Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. Am J Physiol Endocrinol Metab. 2007 Apr; 292(4):E1079-86. PMID: 17164441.
      View in: PubMed
    115. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer. 2006 May 08; 94(9):1221-5. PMID: 16570048.
      View in: PubMed
    116. Tsiodras S, Kelesidis T, Kelesidis I, Voumbourakis K, Giamarellou H. Mycoplasma pneumoniae-associated myelitis: a comprehensive review. Eur J Neurol. 2006 Feb; 13(2):112-24. PMID: 16490040.
      View in: PubMed
    117. Chan JL, Stoyneva V, Kelesidis T, Raciti P, Mantzoros CS. Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin. Diabetologia. 2006 Jan; 49(1):169-73. PMID: 16362815.
      View in: PubMed
    118. Tsiodras S, Kelesidis I, Kelesidis T, Stamboulis E, Giamarellou H. Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect. 2005 Dec; 51(5):343-54. PMID: 16181677.
      View in: PubMed